ROCKVILLE, Md., Aug. 4, 2008 (PRIME NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today a settlement of an arbitration proceeding against Inhibitex, Inc., effective August 1, 2008. Under the terms of the settlement, Inhibitex agreed to pay Nabi a total of $2.2 million, $1.7 million in connection with the execution of settlement and $0.5 million by October 15, 2008 with 5% interest from August 1, 2008.
